Clinical Trial Update: EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating EMLA Topical Cream to reduce pain from intradermal Tc-99 injections used for lymphoscintigraphy in patients with skin cancers;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Cutaneous Squamous Cell Carcinoma
• Merkel Cell Carcinoma

Drugs mentioned

• EMLA Topical Cream (Lidocaine 2.5% / Prilocaine 2.5% topical anesthetic)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Cutaneous Melanoma, Merkel Cell Carcinoma | Phase 2 | Status: RECRUITING